NUMYTRIS Trademark

Trademark Overview

On Wednesday, March 25, 2020, a trademark application was filed for NUMYTRIS with the United States Patent and Trademark Office. The USPTO has given the NUMYTRIS trademark a serial number of 88846956. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 16, 2023. This trademark is owned by Levo Therapeutics, Inc.. The NUMYTRIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders
numytris

General Information

Serial Number88846956
Word MarkNUMYTRIS
Filing DateWednesday, March 25, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLevo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSkokie, IL 60077
Party NameLevo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSkokie, IL 60077

Trademark Events

Event DateEvent Description
Monday, October 16, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 8, 2023SOU EXTENSION 5 GRANTED
Thursday, February 16, 2023SOU EXTENSION 5 FILED
Friday, March 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 16, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 17, 2022SOU EXTENSION 4 GRANTED
Wednesday, August 17, 2022SOU EXTENSION 4 FILED
Wednesday, August 17, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU EXTENSION 3 GRANTED
Wednesday, February 16, 2022SOU EXTENSION 3 FILED
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Monday, January 31, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 31, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 31, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021SOU EXTENSION 2 GRANTED
Wednesday, August 18, 2021SOU EXTENSION 2 FILED
Wednesday, August 18, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 26, 2021SOU EXTENSION 1 GRANTED
Friday, February 26, 2021SOU EXTENSION 1 FILED
Friday, February 26, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 16, 2020ASSIGNED TO EXAMINER
Monday, March 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 28, 2020NEW APPLICATION ENTERED

Related Keywords

numytris pharmaceutical disorders treatment products preparations neurodevelopmental metabolic willi prader syndrome